Skeletal muscle plasticity, fitness and health after SCI

脊髓损伤后骨骼肌的可塑性、健康和健康

基本信息

  • 批准号:
    6536233
  • 负责人:
  • 金额:
    $ 24.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-10 至 2006-06-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) Physical inactivity after spinal cord injury (SCI) leads to low exercise capacity and increased risk of cardio vascular disease mortality. Exercise conditioning, which moves an individual from the lowest to the next quintile for aerobic fitness, reduces mortality. Our long-term goal is to develop therapies that maintain cardiovascular health after SCI. We have shown that the major adaptation of skeletal muscle within 6 months of SCI is atrophy. We reversed this sarcopenia using our simplistic electromyostimulation (EMS) conditioning protocol. In contrast, it has been difficult to evoke hypertrophy in chronic patients. We hypothesize, therefore, that a meaningful increase in aerobic exercise capacity during functional electrical stimulation (FES) exercise will occur in short term but not chronic patients after EMS conditioning because the limitation in peak VO2 after SCI is a small active muscle mass. Metabolism/perfusion mismatch that results in fatigue and low force during EMS may explain the limited hypertrophy in chronic SCI. Lack of up regulation of endogenous growth factors, i.e., IGF1, which we have shown to occur in able-bodied individuals after EMS, may also limit muscle growth. We will also test these hypotheses. Patients within 4 to 8 months of or at least 3 years after complete SCI will be examined in studies with the following specific aims: 1) FES, which evokes dynamic knee extension exercise of m. quadriceps femoris, will be done to measure peak VO2 before and after EMS conditioning designed to evoke hypertrophy; 2) 12 weeks of EMS conditioning will be used to assess the hypertrophic capacity of m. quadriceps femoris. Coupled lengthening and shortening actions will be evoked. Fiber and whole muscle size will be assessed in biopsies of m. vastus lateralis and magnetic resonance images of m. quadriceps femoris; 3) Fatigue, blood flow and metabolism to perfusion matching of m. quadriceps femoris will be assessed. Force will be measured during EMS. Limb blood flow will be measured after cuff ischemia using duplex Doppler. Muscle oxidative capacity will be assessed using biopsies (metabolic enzymes) and near infrared spectrophotometry (state of oxygenation); and 4) Up regulation of component(s) of the skeletal muscle IGF-1 autocrine/paracrine system and responsiveness of satellite cells to IGF- 1 signaling will be measured after EMS of m. quadriceps femoris. These studies are significant. They assess pathophysiology (perfusion /metabolism mismatch and/or lack of up regulation of muscle growth factors), impairment (inability to evoke hypertrophy) and functional limitation (low aerobic exercise capacity) which lead to increased risk of cardiorespiratory disease mortality
描述:(由申请人提供)脊髓损伤后缺乏体力活动 损伤(SCI)导致运动能力降低,增加心脏病风险 血管疾病死亡率。锻炼条件反射, 从最低到下一个五分之一的有氧健身,降低死亡率。 我们的长期目标是开发维持心血管健康的疗法 SCI之后我们已经证明,骨骼肌的主要适应性在6 脊髓损伤数月是萎缩。我们用我们简单的 电肌肉刺激(EMS)调节方案。相比之下, 难以引起慢性患者的肥大。因此,我们假设, 有氧运动能力的显著增加, 电刺激(FES)运动会在短期内发生,但不会长期发生 EMS预处理后的患者,因为SCI后峰值VO 2的限制是 一小块活跃的肌肉。代谢/灌注不匹配导致 EMS过程中的疲劳和低力可能解释了慢性心肌肥厚的局限性。 SCI.缺乏内源性生长因子的上调,即,IGF 1,我们 已经证明发生在身体健全的人后EMS,也可能限制肌肉 增长我们也将测试这些假设。4至8个月内的患者或 完成SCI后至少3年将在研究中进行检查, 以下具体目标:1)FES,引起动态膝关节伸展运动 分枝将进行股四头肌,以测量EMS前后的峰值VO 2 旨在引起肥大的预处理; 2)12周EMS预处理 将用于评估M的肥大能力。股四头肌 将诱发耦合的延长和缩短动作。纤维和全 肌肉大小将在M的活组织检查中评估。股外侧肌和磁 共振成像的m。股四头肌; 3)疲劳,血流量和 代谢与灌注的匹配。将评估股四头肌。 将在EMS期间测量力。袖带后测量肢体血流量 多普勒显示缺血。肌肉氧化能力将使用 活组织检查(代谢酶)和近红外分光光度法( 氧合);和4)骨骼肌IGF-1的组分的上调 自分泌/旁分泌系统与卫星细胞对IGF- 1的反应性 将在EMS为m之后测量信令。股四头肌这些研究 意义重大他们评估病理生理学(灌注/代谢不匹配 和/或缺乏肌肉生长因子的上调)、损伤(不能 引起肥大)和功能限制(低有氧运动能力) 导致心肺疾病死亡风险增加

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin K. McCully其他文献

Muscle-specific endurance of the trapezius muscles using electrical twitch mechanomyography
使用电抽搐肌力描记法测量斜方肌的肌肉特异性耐力
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kevin K. McCully;P. Prins;K. Mistry;T. B. Willingham
  • 通讯作者:
    T. B. Willingham
Validation of scores from a telephone administered multiple sclerosis walking scale-12 in persons with multiple sclerosis.
对多发性硬化症患者通过电话进行多发性硬化症步行量表 12 评分的验证。
  • DOI:
    10.1016/j.msard.2024.105715
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    4
  • 作者:
    R. W. Motl;Prudence Plummer;Deborah Backus;Jeffrey R. Hebert;Whitney N. Neal;Alexander Ng;John Lowman;Francois Bethoux;Hollie Schmidt;R. McBurney;Kevin K. McCully;Gary R Cutter
  • 通讯作者:
    Gary R Cutter
In Vivo Assessment of Mitochondrial Dysfunction in Clinical Populations Using Near-Infrared Spectroscopy
使用近红外光谱对临床人群线粒体功能障碍进行体内评估
  • DOI:
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    4
  • 作者:
    T. B. Willingham;Kevin K. McCully
  • 通讯作者:
    Kevin K. McCully

Kevin K. McCully的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin K. McCully', 18)}}的其他基金

Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease
氧气引导治疗可实现外周动脉疾病的最佳康复
  • 批准号:
    10324798
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease
氧气引导治疗可实现外周动脉疾病的最佳康复
  • 批准号:
    10545825
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring
预防 1 型糖尿病的血管并发症:肌肉代谢监测
  • 批准号:
    9906313
  • 财政年份:
    2017
  • 资助金额:
    $ 24.29万
  • 项目类别:
Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring
预防 1 型糖尿病的血管并发症:肌肉代谢监测
  • 批准号:
    10022325
  • 财政年份:
    2017
  • 资助金额:
    $ 24.29万
  • 项目类别:
CHRONIC FATIGUE SYNDROME
慢性疲劳综合症
  • 批准号:
    6977478
  • 财政年份:
    2004
  • 资助金额:
    $ 24.29万
  • 项目类别:
Muscle Plasticity, Fitness, and Health after Spinal Cord Injury
脊髓损伤后的肌肉可塑性、健身和健康
  • 批准号:
    7615670
  • 财政年份:
    2001
  • 资助金额:
    $ 24.29万
  • 项目类别:
Muscle Plasticity, Fitness, and Health after Spinal Cord Injury
脊髓损伤后的肌肉可塑性、健身和健康
  • 批准号:
    7371659
  • 财政年份:
    2001
  • 资助金额:
    $ 24.29万
  • 项目类别:
Muscle Plasticity, Fitness, and Health after Spinal Cord Injury
脊髓损伤后的肌肉可塑性、健身和健康
  • 批准号:
    7800945
  • 财政年份:
    2001
  • 资助金额:
    $ 24.29万
  • 项目类别:
Muscle Plasticity, Fitness, and Health after Spinal Cord Injury
脊髓损伤后的肌肉可塑性、健身和健康
  • 批准号:
    8069998
  • 财政年份:
    2001
  • 资助金额:
    $ 24.29万
  • 项目类别:
Muscle Plasticity, Fitness, and Health after Spinal Cord Injury
脊髓损伤后的肌肉可塑性、健身和健康
  • 批准号:
    8277811
  • 财政年份:
    2001
  • 资助金额:
    $ 24.29万
  • 项目类别:

相似海外基金

Paracrine and autocrine IL-6 as drivers of treatment resistance in medulloblastoma
旁分泌和自分泌 IL-6 作为髓母细胞瘤治疗抵抗的驱动因素
  • 批准号:
    468060
  • 财政年份:
    2022
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Operating Grants
Targeting Autocrine Hepatocyte Growth Factor (HGF) Production as a Therapeutic Modality in Acute Myeloid Leukemia (AML)
靶向自分泌肝细胞生长因子 (HGF) 的产生作为急性髓系白血病 (AML) 的治疗方式
  • 批准号:
    10589002
  • 财政年份:
    2022
  • 资助金额:
    $ 24.29万
  • 项目类别:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
自分泌和旁分泌足细胞信号会降低老年肾脏的肾小球功能/健康
  • 批准号:
    10698100
  • 财政年份:
    2022
  • 资助金额:
    $ 24.29万
  • 项目类别:
Elucidating the role of autocrine TNF signaling in maintaining human regulatory T cell identity
阐明自分泌 TNF 信号传导在维持人类调节性 T 细胞身份中的作用
  • 批准号:
    BB/W001055/1
  • 财政年份:
    2022
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Research Grant
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10615236
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
Rôle autocrine des exosomes sécrétés par le muscle dans un contexte de diabète de type 2
2 型糖尿病背景下肌肉中外泌体的自分泌作用
  • 批准号:
    466812
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Studentship Programs
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10296083
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
  • 批准号:
    10469480
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
线粒体活性氧在视网膜神经节细胞中充当自分泌神经调节剂
  • 批准号:
    10157645
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
The procuction of inflammatory mediators anc autocrine via clock genes in RA-FLS
RA-FLS 中通过时钟基因产生炎症介质和自分泌
  • 批准号:
    21K16288
  • 财政年份:
    2021
  • 资助金额:
    $ 24.29万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了